Epilepsy Clinical Trials in Birmingham, Alabama

4 studies are recruiting for epilepsy in Birmingham, Alabama right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. Diagnosing Epilepsy To EffeCT Change

    The purpose of this research is to address the challenges of diagnosing and long-term management of epilepsy in participants whose seizures are not well captured by standard electroencephalography (EEG) tests and who cannot use or are not able to use more standard monitoring techniques. This resear…

    Stage
    Not phased
    Ages
    18 to 75
    Site
    UAB Epilepsy Center, Birmingham, Alabama
    Locations
    21 in total
    Run by
    Epiminder America, Inc.

    See if you can join NCT07110337 on ClinicalTrials.gov

  2. Diagnosing Epilepsy To EffeCT Change Long-Term Follow-Up

    The purpose of this research is to address the challenges of correctly monitoring, managing, and diagnosing epilepsy in participants whose seizures are not well captured by standard electroencephalography (EEG) tests and who cannot use or are not able to use more standard monitoring techniques. Thi…

    Stage
    Not phased
    Ages
    18 to 75
    Site
    UAB Epilepsy Center, Birmingham, Alabama
    Locations
    18 in total
    Run by
    Epiminder America, Inc.

    See if you can join NCT07110454 on ClinicalTrials.gov

  3. Stimulation-Induced Changes in Fronto-Limbic Network

    The purpose of this research is to better understand how emotion processing unfolds in the brain using stereoelectroencephalography (sEEG) and direct brain stimulation. This study will use standard behavioral emotion processing tasks combined with neural recording and direct brain stimulation to as…

    Stage
    Not phased
    Ages
    18 and older
    Site
    Epilepsy Monitoring Unit UAB Hospital, Birmingham, Alabama
    Run by
    University of Alabama at Birmingham

    See if you can join NCT05854160 on ClinicalTrials.gov

  4. Stopping TSC Onset and Progression 2B: Sirolimus TSC Epilepsy Prevention Study

    This trial is a Phase II randomized, double-blind, placebo controlled multi-site study to evaluate the safety and efficacy of early sirolimus to prevent or delay seizure onset in TSC infants. This study is supported by research funding from the Office of Orphan Products Division (OOPD) of the US Fo…

    Stage
    Phase 2
    Ages
    0 to 0
    Site
    University of Alabama at Birmingham, Birmingham, Alabama
    Locations
    11 in total
    Run by
    Darcy Krueger

    See if you can join NCT05104983 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.